Dose Escalation/Dose Expansion Study of YBL-006 in Patients With Advanced Solid Tumors
Clinical trial NCT04450901 · UNKNOWN
Trial details
- NCT number
- NCT04450901
- Sponsor
- Y Biologics Inc.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2023-03-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.